Metabolic Bone Disease in Children With Transfusion-Dependent Thalassemia

Koushik Handattu1, Shrikiran Aroor2, Pushpa Kini2

  • 1Department of Pediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka. Correspondence to: Dr Koushik Handattu, Assistant Professor, Department of Paediatrics, Kasturba Medical College (Manipal Academy of Higher Education), Manipal, Karnataka. koushik.h@manipal.edu.

Indian Pediatrics
|August 29, 2022
PubMed

Insights

Transfusion-dependent thalassemia (TDT) patients frequently experience endocrine deficiencies and metabolic bone disease. Vertebral fractures are a significant concern, even in adolescents, highlighting the need for early screening and intervention.

Area of Science:

  • Endocrinology
  • Metabolic Bone Disease
  • Pediatric Hematology

Background:

  • Transfusion-dependent thalassemia (TDT) is a chronic condition requiring lifelong blood transfusions.
  • Patients with TDT are at increased risk for endocrine dysfunction and metabolic bone abnormalities due to iron overload and chronic disease.
  • Early detection of these complications is crucial for managing patient health and preventing long-term sequelae.

Purpose of the Study:

  • To investigate the prevalence of metabolic bone disease and endocrinopathies in children and adolescents with TDT.
  • To identify specific endocrine deficiencies and bone abnormalities in this patient cohort.
  • To assess the association between vertebral fractures and endocrine dysfunction in TDT patients.

Main Methods:

  • A prospective study involving 37 patients with TDT (age > 5 years) receiving regular blood transfusions.
  • Comprehensive evaluation included screening for short stature, delayed puberty, diabetes mellitus, hypothyroidism, adrenal insufficiency, and hypoparathyroidism.
  • Patients > 10 years underwent thoracolumbar spine X-rays and dual-energy X-ray absorptiometry (DXA) for bone density assessment.

Main Results:

  • The most common endocrine deficiency was hypogonadism (62%), followed by short stature and abnormal glucose metabolism.
  • Vitamin D insufficiency/deficiency was observed in 60% of patients; hypocalcemia in 2 patients.
  • Low bone mass was present in 8 patients, and 4 patients had osteoporosis with vertebral fractures, often associated with hypogonadism and multiple endocrine deficiencies.

Conclusions:

  • Vertebral fractures can occur in the second decade of life in TDT patients, frequently linked to hypogonadism and other endocrine issues.
  • Early screening for metabolic bone disease and endocrinopathies is essential in TDT management.
  • Proactive strategies are needed to prevent vertebral fractures and associated complications in this population.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
482
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
233
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
53.4K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
143.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
70